During the past decade, KEM Hospital Research Centre conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KEM Hospital Research Centre" #1 sponsor was "Pfizer" with 3 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Shire" with 2 trials sponsored and "Asahi Kasei Pharma America Corporation" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KEM Hospital Research Centre" #1 collaborator was "All India Institute of Medical Sciences, New Delhi" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "KEM Hospital Research Centre" with 1 trials as a collaborator and "Mulago Hospital, Uganda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "KEM Hospital Research Centre" are "Colitis, Ulcerative" (2 trials), "Gaucher Disease, Type 1" (2 trials), "Gaucher Disease, Type 3" (2 trials), "Vaccines" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "KEM Hospital Research Centre" in a lesser frequency.

Most popular intervention types in "KEM Hospital Research Centre" are "Drug" (15 trials), "Biological" (5 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "13vPnC" (2 trials), "Etrolizumab" (2 trials), "placebo" (2 trials) and "velaglucerase alfa" (2 trials). Other intervention names were less common.

The vast majority of trials in "KEM Hospital Research Centre" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "KEM Hospital Research Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in KEM Hospital Research Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in KEM Hospital Research Centre, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".